Inulin increases short-term markers for colonic fermentation similarly in healthy and hyperinsulinaemic humans

European Journal of Clinical Nutrition

Volumn 65, Issue 12, 2011, Pages 1279-1286

  Fernandes, J ^a   Vogt, J ^a   Wolever, T M S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

acetate; colonic fermentation; free fatty acids; hyperinsulinaemia; inulin; short chain fatty acids

Indexed keywords

ACETIC ACID; ASPARTATE AMINOTRANSFERASE; BUTYRIC ACID; C PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROGEN; INSULIN; INULIN; LOW DENSITY LIPOPROTEIN; METHANE; PROPIONIC ACID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COLONIC FERMENTATION; CONTROLLED STUDY; DIET RESTRICTION; DRINKING; FEMALE; FERMENTATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; WAIST CIRCUMFERENCE;

ACETATES; ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; BREATH TESTS; COLON; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; DIETARY FIBER; FATTY ACIDS, VOLATILE; FEMALE; FERMENTATION; GLUCOSE; HUMANS; HYDROGEN; HYPERINSULINISM; INULIN; MALE; METHANE; SINGLE-BLIND METHOD;

EID: 82955163129     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.116     Document Type: Article

References (37)

1. Akanji AO, Humphreys S, Thursfield V, Hockaday TD (1989). The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects. Clin Chim Acta 185, 25-34. (Pubitemid 19272530)
2. Boden G (2002). Interaction between free fatty acids and glucose metabolism. Curr Opin Nutr Metab Care 5, 545-549. (Pubitemid 40684651)
3. Boden G, Shulman GI (2002). Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and B-cell dysfunction. Eur J Clin Invest 32, S14-S23.
4. Brighenti F, Benini L, Del Rio D, Casiraghi C, Pellegrini N, Scazzina F (2006). Colonic fermentation of indigestible carbohydrates contributes to the second-meal effect. Am J Clin Nutr 83, 817-822. (Pubitemid 44713145)
5. Caballero B (2007). The global epidemic of obesity: an overview. Epidemiol Rev 29, 1-5. (Pubitemid 47229648)
6. Crouse JR, Gerson CD, Decarli LM, Lieber S (1968). Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man. J Lipid Res 9, 509-512.
7. Del Boca J, Flatt JP (1969). Fatty acid synthesis from glucose and acetate and the control of lipogenesis in adipose tissue. Eur J Biochem 11, 127-134.
8. De Munter JSL, Hu FB, Spiegelman D, Franz M, van Dam RM (2007). Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 4, 1385-1394.
9. Ferchaud-Roucher V, Pouteau E, Piloquet H, Zä?r Y, Krempf M (2005). Colonic fermentation from lactulose inhibits lipolysis in overweight subjects. Am J Physiol Endocrinol Metab 289, E716-E720. (Pubitemid 41356096)
10. Freeland KR, Wilson C, Wolever TMS (2009). Adaptation of colonic fermentation and glucagon-like peptide-1 (GLP-1) secretion with increased wheat fibre intake for 1-year in hyperinsulinaemic humans. Br J Nutr 103, 82-90.
11. Gibson GR, Beatty ER, Wang X, Cummings JH (1995). Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975-982.
12. Greenberg AS, McDaniel ML (2002). Identifying the links between obesity, insulin resistance and b-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 32(Suppl 3), 24-34. (Pubitemid 41704997)
13. Jenkins DJA, Wolever TMS, Jenkins A, Brighenti F, Vuksan V, Rao AV et al. (1991). Specific types of colonic fermentation may raise low-density- lipoprotein-cholesterol concentrations. Am J Clin Nutr 54, 141-147. (Pubitemid 21898929)
14. Knowles SE, Jarrett IG, Filsell OH, Ballard FJ (1974). Production and utilization of acetate in mammals. Biochem J 142, 401-411.
15. Liese AD, Schulz M, Fang F, Wolever TMS, D'Agostino Jr RB, Sparks KC (2005). Dietary glycemic index and glycemic load, carbohydrate and fiber intake, and measures of insulin sensitivity, secretion, and adiposity in the Insulin Resistance Atherosclerosis Study. Diabetes Care 28, 2832-2838. (Pubitemid 43942911)
16. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE et al. (1999). Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 70, 412-419. (Pubitemid 29407162)
17. Luong A, Hannah V, Brown M, Goldstein J (2000). Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J Biol Chem 275, 458-466.
18. McGarry JD (2002). Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51, 7-18.
19. Piloquet H, Ferchaud-Roucher V, Duengler F, Zair Y, Maugere P, Krempf M (2003). Insulin effects on acetate metabolism. Am J Physiol Endocrinol Metab 285, E561-E565. (Pubitemid 37010834)
20. Popkin BM, Gordon-Larsen P (2004). The nutrition transition: worldwide obesity dynamics and their determinants. Int J Obes Relat Metab Disord 28(Suppl), S2-S9. (Pubitemid 39564310)
21. Prentki M, Nolan CJ (2006). Islet b cell failure in type 2 diabetes. J Clin Invest 116, 1802-1812. (Pubitemid 44033300)
22. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN (2005). Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 82, 559-567.
23. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN (2003). Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 46, 659-665. (Pubitemid 36814018)
24. Rossi M, Corradini C, Amaretti A, Nicolini M, Pompei A, Zanoni S et al. (2005). Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and fecal cultures. Appl Environ Microbiol 71, 6150-6158. (Pubitemid 41456913)
25. Salmeron J,Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC (1997). Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472-477. (Pubitemid 27074331)
26. Schulze MB, Schulz M, Heidemann C, Schienkiewitz A, Hoffmann K, Boeing H (2007). Fiber and magnesium intake and incidence of type 2 diabetes. A prospective study and meta-analysis. Arch Intern Med 167, 956-965.
27. Sone H, Shimano H, Sakakura Y, Inoue N, Amemiya-Kudo M, Yahagi N et al. (2002). Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am J Physiol Endocrinol Metab 282, E222-E230.
28. Tarini J, Wolever TMS (2010). The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35, 9-16.
29. Todesco T, Zamboni M, Armellini F, Bissoli L, Turcato E, Piemonte G et al. (1993). Plasma acetate levels in a group of obese diabetic, obese normoglycemic, and control subjects and their relationships with other blood parameters. Am J Gastroenterol 88, 751-755. (Pubitemid 23132835)
30. Tollinger CD, Vreman HJ, Wiener MW (1979). Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding and various diseases. Clin Chem 25, 1787-1790. (Pubitemid 10207409)
31. Weickert MO, Mohlig M, Koebnick C, Holst JJ, Namsolleck P, Ristow M et al. (2005). Impact of cereal fibre on glucose-regulating factors. Diabetologia 48, 2343-2353. (Pubitemid 41618927)
32. Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053. (Pubitemid 38579764)
33. Wolever TM, Josse RG, Leiter LA, Chiasson JL (1997). Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805-811. (Pubitemid 27300625)
34. Wolever TM, Radmard R, Chiasson J-L, Hunt JA, Josse RG, Palmason C et al. (1995). One-year acarbose therapy raises fasting serum acetate in diabetic patients. Diabet Med 12, 164-172.
35. Wolever TMS, Brighenti F, Royall D, Jenkins AL, Jenkins DJA (1989). Effect of rectal infusion of short chain fatty acids in human subjects. Am J Gastroenterol 84, 1027-1033. (Pubitemid 19237987)
36. World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. World Health Organization: Geneva. (WHO technical report series 894).
37. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM (2000). Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23, 171-175. (Pubitemid 30071019)